Press Releases
-
May 14, 2019- Preparing to file first IND in Q3 2019
Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and...
-
May 8, 2019Biostage to Host Conference Call to Discuss First Quarter 2019 Financial Results and Business Update- Conference Call with Live Audio Webcast on Tuesday May 14th at 9:00 AM ET -
Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, announced today that it...
-
Mar 28, 2019- Pre-clinical and human compassionate use clinical evidence support IND filing mid-year 2019
Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and...
-
Mar 21, 2019- Conference Call with Live Audio Webcast on Thursday March 28th at 9:00 AM ET -
Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, announced today that it...
-
Jan 28, 2019
Dennis Wigle, M.D., Ph.D, chair of thoracic surgery at Mayo Clinic in Rochester, Minnesota, speaking at the Society of Thoracic Surgeons Tech-Con 2019 meeting on January 26, announced for the...
